Close X
Tuesday, October 8, 2024
ADVT 
National

Women grads more likely to access CERB: StatCan

Darpan News Desk The Canadian Press, 06 Jul, 2022 09:41 AM
  • Women grads more likely to access CERB: StatCan

OTTAWA - A new Statistics Canada study finds women post-secondary graduates were more likely to receive the Canada Emergency Response Benefit in 2020 than male graduates.

The study also finds that those who graduated in 2018 with a college-level certificate or diploma were more likely to access the benefit than the general working population.

The federal government introduced the CERB in 2020 to provide financial support for Canadians who lost income due to COVID-19.

Statistics Canada compared the proportion of 2010 to 2018 graduates who received CERB based on educational and socio-demographic characteristics to the proportion of all workers who received the benefit.

The study says this group of graduates was of particular interest “because while they are younger and typically have less seniority, having a recent education qualification may have helped them keep their employment.”

Overall, 2010 to 2018 graduates were less likely to access the benefit than the general working population.

Of all workers, 35.2 per cent received CERB in 2020.

Recent graduates were more likely to have received CERB, with a third of 2018 graduates receiving the benefit compared to a fifth of 2010 graduates.

Those with more advanced post-secondary degrees were also less likely to access CERB, with only 13.3 per cent of 2018 graduates with a doctoral degree receiving the benefit.

Among 2018 graduates, those from college and university programs in visual and performing arts, as well as communication technologies, had the highest proportion of graduates receiving CERB, with over 50 per cent accessing the benefit.

Additionally, 2018 graduates with a college-level diploma or undergraduate degree in mathematics, computer and information sciences were the least likely to receive CERB in comparison to graduates from other fields.

Women weren’t just more likely to access the benefit among 2018 graduates — they were also more likely to receive it among the general working population.

MORE National ARTICLES

218 COVID19 cases for Friday

218 COVID19 cases for Friday
There are 260 individuals hospitalized with COVID-19 and 50 are in intensive care. In the past 24 hours, two new deaths have been reported, for an overall total of 2,983.

218 COVID19 cases for Friday

Feds' bill could hit digital creators — YouTube

Feds' bill could hit digital creators — YouTube
The platform says proposed legislation obliging platforms to promote Canadian content risks downgrading the popularity of that content abroad — and the foreign earnings many Canadian YouTubers rely on.    

Feds' bill could hit digital creators — YouTube

Feds give another $2B to address health backlogs

Feds give another $2B to address health backlogs
The money, included in the newly tabled Bill C-17, follows a $4-billion top-up to the federal health transfer last summer and is expected to be a one-time payment, distributed equally based on population.

Feds give another $2B to address health backlogs

ICBC relief rebate coming for drivers

ICBC relief rebate coming for drivers
Most ICBC customers with a basic auto insurance policy during the month of February will be eligible for the $110 relief rebate. Most commercial customers will receive a rebate of $165 because they generally incur higher expenses.    

ICBC relief rebate coming for drivers

Climate protests planned across Canada today

Climate protests planned across Canada today
Dozens of other events are planned in cities across Canada, including Quebec City, Calgary and Vancouver. Using the hashtag #Peoplenotprofit, organizers are denouncing the role of colonialism and capitalism in causing climate change and are calling for reparations to be paid to those most impacted.

Climate protests planned across Canada today

WHO rejects made-in-Canada COVID-19 vaccine

WHO rejects made-in-Canada COVID-19 vaccine
Health Canada authorized Medicago's two-dose Covifenz vaccine in February for adults 18 to 64. In clinical trials it was more than 70 per cent effective at preventing COVID-19 infections and 100 per cent effective against severe illness, before the Omicron wave.

WHO rejects made-in-Canada COVID-19 vaccine